Cell Bauhaus-preview

Cellbauhaus

Cell Bauhaus

Private

MelbourneHealthcare & Life Scienceshttps://cellbauhaus.com

Last Round

Grant

Feb 3, 2025

Total Funding Raised

$3.23M

Company Overview

Cell Bauhaus is a software and biotechnology company that develops digital twins of biological cells to simulate and predict the effects of genetic changes on cellular behavior.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Drug Discovery, Medical AI, Clean Manufacturing

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

biological digital twinsin silico simulationsynthetic biologycomputational biologysynbiovirtual cell technologyorganism engineeringprecision medicinebiomanufacturingmechanistic modelingdrug discoveryhybrid modelingsimulation platformdigital bio

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cell Bauhaus Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cell Bauhaus Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Feb 3, 2025
Pre Seed	Oct 8, 2024

View all Funding Rounds

Key People

Founding team and executive leadership

Michael Stumpf

Co-Founder And Chief Scientific Officer

Founding Team

Megan Coomer

Co-founder Chief Executive Officer

Founding Team

Cell Bauhaus Investors

Notable investors and investment history

Investor	Rounds
Gates Family Foundation	Grant
Bill & Melinda Gates Foundation	Grant
Tin Alley Ventures	Pre Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Feb 3, 2025
Secured $1.9M in grant funding.

View all signals

Cell Bauhaus Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Cell Bauhaus Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cell Bauhaus's valuation, stock price, and market status.

Firmographic Details

HeadquartersMelbourne

Employee Range12

Year Founded2023

Last FundingFeb 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.